Protection against Omicron BA.1/BA.2 severe disease 0–7 months after BNT162b2 booster

Authors :: Ofra Amir
Yair Goldberg
Micha Mandel
Yinon M. Bar-On
Omri Bodenheimer
Laurence Freedman
Sharon Alroy-Preis
Nachman Ash
Amit Huppert
Ron Milo
Source :: Communications Biology, Vol 6, Iss 1, Pp 1-7 (2023)
Publication Year :: 2023
Publisher :: Nature Portfolio, 2023.
Abstract: Patient data from the Israeli Ministry of Health demonstrates that a 3rd dose of BNT162b2 is effective in reducing Omicron BA.1/BA.2 severe disease and does not wane over the seven month study period as well as that a fourth dose further improves the protective features of vaccination.

Full Text Access

Tools